Fortress Biotech (FBIO) Loans and Notes Receivables: 2016-2018
Historic Loans and Notes Receivables for Fortress Biotech (FBIO) over the last 2 years, with Sep 2018 value amounting to $1.6 million.
- Fortress Biotech's Loans and Notes Receivables rose 26.87% to $1.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.6 million, marking a year-over-year increase of 26.87%. This contributed to the annual value of $1.6 million for FY2017, which is 5.61% down from last year.
- According to the latest figures from Q3 2018, Fortress Biotech's Loans and Notes Receivables is $1.6 million, which was up 0.75% from $1.6 million recorded in Q2 2018.
- In the past 5 years, Fortress Biotech's Loans and Notes Receivables ranged from a high of $1.7 million in Q4 2016 and a low of $1.3 million during Q3 2017.
- Its 3-year average for Loans and Notes Receivables is $1.5 million, with a median of $1.6 million in 2018.
- Its Loans and Notes Receivables has fluctuated over the past 5 years, first fell by 5.61% in 2017, then climbed by 26.87% in 2018.
- Fortress Biotech's Loans and Notes Receivables (Quarterly) stood at $1.7 million in 2016, then dropped by 5.61% to $1.6 million in 2017, then grew by 26.87% to $1.6 million in 2018.
- Its last three reported values are $1.6 million in Q3 2018, $1.6 million for Q2 2018, and $1.5 million during Q1 2018.